New

Asthma Therapeutics Market

2021

Asthma Therapeutics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Dry powder inhalers, Metered dose inhalers, Mist inhalers, Nebulizer); Drug Class (Anti-inflammatory drugs, Bronchodilators, Combination therapy); Route of administration (Oral, Inhaled, Intravenous, Subcutaneous) and Geography

| Report Code: TIPRE00004065 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming

Market Insights

Asthma Therapeutics Market 2028 By Product Type, Drug Class, Route of administration and Geography | The Insight Partners

Covid
Assesing the covid-19 impact?
Get the Latest COVID-19 Analysis on this market
Request Now
Happy to join you in your fight against the COVID-19 economic pandemic!

MARKET OVERVIEW



Asthma is a chronic lung disease in which inflammation causes the bronchi to swell and narrow, resulting in breathing difficulties that can range from mild to life-threatening in considerable number of cases. The symptoms of asthma include, chest tightness, cough ,shortness of breath and wheezing. Asthma is caused by a number of environmental factors, including allergen exposure and air pollution. Asthma has been proven to have no cure, although it can be managed with early and effective asthma therapy. Anti-inflammatory drugs, corticosteroids, long-acting beta-agonists (LABA), and leukotriene modifiers are among the therapies used to treat asthma.

MARKET SCOPE



The "Global Asthma Therapeutics Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of the asthma therapeutics market with detailed market segmentation by product type, drug class, route of administration. The report provides key statistics on the market status of the leading asthma therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  • Based on product type the market is segmented as, dry powder inhalers, metered dose inhalers, mist inhalers and nebulizer.
  • Based on drug class the market is segmented as, anti-inflammatory drugs, bronchodilators and combination therapy.
  • Based on route of administration the market is segmented as, oral, inhaled, intravenous and subcutaneous.

MARKET DYNAMICS


Drivers:



  • Increasing incidences of asthma and other respiratory disorders.
  • Various risk factors such as, exposure to pollution, allergens, chemicals, practicing unhealthy lifestyles such as smoking are also expected to spur the market growth.
  • Presence of robust pipeline of agents to manage asthma is also expected to spur market growth during the forecast period.

Restraints:



  • However, patent expiration of drugs and high cost of asthma treatment are expected to restrain market growth during the forecast period.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The asthma therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the asthma therapeutics market in these regions.

IMPACT OF COVID-19 ON ASTHMA THERAPEUTICS MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. According to the current market situation, the report further assesses the present and future effects of the COVID-19 pandemic on the overall market, giving more reliable and authentic projections In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the asthma therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from asthma therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for asthma therapeutics in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the asthma therapeutics market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
  • Koninklijke Philips N.V
  • AstraZeneca
  • GlaxoSmithKline Plc.
  • Teva Pharmaceutical Industries Ltd.
  • Boehringer Ingelheim International GmbH
  • Sanofi
  • Cipla Inc
  • Intas Pharmaceuticals Ltd
  • Merck Sharp and Dohme Corp
  • F. Hoffmann-La Roche Ltd
    The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
  • TABLE OF CONTENTS

    1. INTRODUCTION
    1.1. SCOPE OF THE STUDY
    1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
    1.3. MARKET SEGMENTATION
    1.3.1 Asthma Therapeutics Market - By Product Type
    1.3.2 Asthma Therapeutics Market - By Drug Class
    1.3.3 Asthma Therapeutics Market - By Route of administration
    1.3.4 Asthma Therapeutics Market - By Region
    1.3.4.1 By Country

    2. KEY TAKEAWAYS

    3. RESEARCH METHODOLOGY

    4. ASTHMA THERAPEUTICS MARKET LANDSCAPE
    4.1. OVERVIEW
    4.2. PORTER'S FIVE FORCES ANALYSIS
    4.2.1 Bargaining Power of Buyers
    4.2.1 Bargaining Power of Suppliers
    4.2.1 Threat of Substitute
    4.2.1 Threat of New Entrants
    4.2.1 Competitive Rivalry
    4.3. EXPERT OPINIONS

    5. ASTHMA THERAPEUTICS MARKET - KEY MARKET DYNAMICS
    5.1. KEY MARKET DRIVERS
    5.2. KEY MARKET RESTRAINTS
    5.3. KEY MARKET OPPORTUNITIES
    5.4. FUTURE TRENDS
    5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

    6. ASTHMA THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
    6.1. ASTHMA THERAPEUTICS - GLOBAL MARKET OVERVIEW
    6.2. ASTHMA THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2028
    6.3. MARKET POSITIONING/MARKET SHARE

    7. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
    7.1. OVERVIEW
    7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
    7.3. DRY POWDER INHALERS
    7.3.1. Overview
    7.3.2. Dry powder inhalers Market Forecast and Analysis
    7.4. METERED DOSE INHALERS
    7.4.1. Overview
    7.4.2. Metered dose inhalers Market Forecast and Analysis
    7.5. MIST INHALERS
    7.5.1. Overview
    7.5.2. Mist inhalers Market Forecast and Analysis
    7.6. NEBULIZER
    7.6.1. Overview
    7.6.2. Nebulizer Market Forecast and Analysis
    8. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - DRUG CLASS
    8.1. OVERVIEW
    8.2. DRUG CLASS MARKET FORECASTS AND ANALYSIS
    8.3. ANTI-INFLAMMATORY DRUGS
    8.3.1. Overview
    8.3.2. Anti-inflammatory drugs Market Forecast and Analysis
    8.4. BRONCHODILATORS
    8.4.1. Overview
    8.4.2. Bronchodilators Market Forecast and Analysis
    8.5. COMBINATION THERAPY
    8.5.1. Overview
    8.5.2. Combination therapy Market Forecast and Analysis
    9. ASTHMA THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
    9.1. OVERVIEW
    9.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
    9.3. ORAL
    9.3.1. Overview
    9.3.2. Oral Market Forecast and Analysis
    9.4. INHALED
    9.4.1. Overview
    9.4.2. Inhaled Market Forecast and Analysis
    9.5. INTRAVENOUS
    9.5.1. Overview
    9.5.2. Intravenous Market Forecast and Analysis
    9.6. SUBCUTANEOUS
    9.6.1. Overview
    9.6.2. Subcutaneous Market Forecast and Analysis

    10. ASTHMA THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
    10.1. NORTH AMERICA
    10.1.1 North America Asthma Therapeutics Market Overview
    10.1.2 North America Asthma Therapeutics Market Forecasts and Analysis
    10.1.3 North America Asthma Therapeutics Market Forecasts and Analysis - By Product Type
    10.1.4 North America Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
    10.1.5 North America Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
    10.1.6 North America Asthma Therapeutics Market Forecasts and Analysis - By Countries
    10.1.6.1 United States Asthma Therapeutics Market
    10.1.6.1.1 United States Asthma Therapeutics Market by Product Type
    10.1.6.1.2 United States Asthma Therapeutics Market by Drug Class
    10.1.6.1.3 United States Asthma Therapeutics Market by Route of administration
    10.1.6.2 Canada Asthma Therapeutics Market
    10.1.6.2.1 Canada Asthma Therapeutics Market by Product Type
    10.1.6.2.2 Canada Asthma Therapeutics Market by Drug Class
    10.1.6.2.3 Canada Asthma Therapeutics Market by Route of administration
    10.1.6.3 Mexico Asthma Therapeutics Market
    10.1.6.3.1 Mexico Asthma Therapeutics Market by Product Type
    10.1.6.3.2 Mexico Asthma Therapeutics Market by Drug Class
    10.1.6.3.3 Mexico Asthma Therapeutics Market by Route of administration
    10.2. EUROPE
    10.2.1 Europe Asthma Therapeutics Market Overview
    10.2.2 Europe Asthma Therapeutics Market Forecasts and Analysis
    10.2.3 Europe Asthma Therapeutics Market Forecasts and Analysis - By Product Type
    10.2.4 Europe Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
    10.2.5 Europe Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
    10.2.6 Europe Asthma Therapeutics Market Forecasts and Analysis - By Countries
    10.2.6.1 Germany Asthma Therapeutics Market
    10.2.6.1.1 Germany Asthma Therapeutics Market by Product Type
    10.2.6.1.2 Germany Asthma Therapeutics Market by Drug Class
    10.2.6.1.3 Germany Asthma Therapeutics Market by Route of administration
    10.2.6.2 France Asthma Therapeutics Market
    10.2.6.2.1 France Asthma Therapeutics Market by Product Type
    10.2.6.2.2 France Asthma Therapeutics Market by Drug Class
    10.2.6.2.3 France Asthma Therapeutics Market by Route of administration
    10.2.6.3 Italy Asthma Therapeutics Market
    10.2.6.3.1 Italy Asthma Therapeutics Market by Product Type
    10.2.6.3.2 Italy Asthma Therapeutics Market by Drug Class
    10.2.6.3.3 Italy Asthma Therapeutics Market by Route of administration
    10.2.6.4 Spain Asthma Therapeutics Market
    10.2.6.4.1 Spain Asthma Therapeutics Market by Product Type
    10.2.6.4.2 Spain Asthma Therapeutics Market by Drug Class
    10.2.6.4.3 Spain Asthma Therapeutics Market by Route of administration
    10.2.6.5 United Kingdom Asthma Therapeutics Market
    10.2.6.5.1 United Kingdom Asthma Therapeutics Market by Product Type
    10.2.6.5.2 United Kingdom Asthma Therapeutics Market by Drug Class
    10.2.6.5.3 United Kingdom Asthma Therapeutics Market by Route of administration
    10.2.6.6 Rest of Europe Asthma Therapeutics Market
    10.2.6.6.1 Rest of Europe Asthma Therapeutics Market by Product Type
    10.2.6.6.2 Rest of Europe Asthma Therapeutics Market by Drug Class
    10.2.6.6.3 Rest of Europe Asthma Therapeutics Market by Route of administration
    10.3. ASIA-PACIFIC
    10.3.1 Asia-Pacific Asthma Therapeutics Market Overview
    10.3.2 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis
    10.3.3 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Product Type
    10.3.4 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
    10.3.5 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
    10.3.6 Asia-Pacific Asthma Therapeutics Market Forecasts and Analysis - By Countries
    10.3.6.1 Australia Asthma Therapeutics Market
    10.3.6.1.1 Australia Asthma Therapeutics Market by Product Type
    10.3.6.1.2 Australia Asthma Therapeutics Market by Drug Class
    10.3.6.1.3 Australia Asthma Therapeutics Market by Route of administration
    10.3.6.2 China Asthma Therapeutics Market
    10.3.6.2.1 China Asthma Therapeutics Market by Product Type
    10.3.6.2.2 China Asthma Therapeutics Market by Drug Class
    10.3.6.2.3 China Asthma Therapeutics Market by Route of administration
    10.3.6.3 India Asthma Therapeutics Market
    10.3.6.3.1 India Asthma Therapeutics Market by Product Type
    10.3.6.3.2 India Asthma Therapeutics Market by Drug Class
    10.3.6.3.3 India Asthma Therapeutics Market by Route of administration
    10.3.6.4 Japan Asthma Therapeutics Market
    10.3.6.4.1 Japan Asthma Therapeutics Market by Product Type
    10.3.6.4.2 Japan Asthma Therapeutics Market by Drug Class
    10.3.6.4.3 Japan Asthma Therapeutics Market by Route of administration
    10.3.6.5 South Korea Asthma Therapeutics Market
    10.3.6.5.1 South Korea Asthma Therapeutics Market by Product Type
    10.3.6.5.2 South Korea Asthma Therapeutics Market by Drug Class
    10.3.6.5.3 South Korea Asthma Therapeutics Market by Route of administration
    10.3.6.6 Rest of Asia-Pacific Asthma Therapeutics Market
    10.3.6.6.1 Rest of Asia-Pacific Asthma Therapeutics Market by Product Type
    10.3.6.6.2 Rest of Asia-Pacific Asthma Therapeutics Market by Drug Class
    10.3.6.6.3 Rest of Asia-Pacific Asthma Therapeutics Market by Route of administration
    10.4. MIDDLE EAST AND AFRICA
    10.4.1 Middle East and Africa Asthma Therapeutics Market Overview
    10.4.2 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis
    10.4.3 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Product Type
    10.4.4 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
    10.4.5 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
    10.4.6 Middle East and Africa Asthma Therapeutics Market Forecasts and Analysis - By Countries
    10.4.6.1 South Africa Asthma Therapeutics Market
    10.4.6.1.1 South Africa Asthma Therapeutics Market by Product Type
    10.4.6.1.2 South Africa Asthma Therapeutics Market by Drug Class
    10.4.6.1.3 South Africa Asthma Therapeutics Market by Route of administration
    10.4.6.2 Saudi Arabia Asthma Therapeutics Market
    10.4.6.2.1 Saudi Arabia Asthma Therapeutics Market by Product Type
    10.4.6.2.2 Saudi Arabia Asthma Therapeutics Market by Drug Class
    10.4.6.2.3 Saudi Arabia Asthma Therapeutics Market by Route of administration
    10.4.6.3 U.A.E Asthma Therapeutics Market
    10.4.6.3.1 U.A.E Asthma Therapeutics Market by Product Type
    10.4.6.3.2 U.A.E Asthma Therapeutics Market by Drug Class
    10.4.6.3.3 U.A.E Asthma Therapeutics Market by Route of administration
    10.4.6.4 Rest of Middle East and Africa Asthma Therapeutics Market
    10.4.6.4.1 Rest of Middle East and Africa Asthma Therapeutics Market by Product Type
    10.4.6.4.2 Rest of Middle East and Africa Asthma Therapeutics Market by Drug Class
    10.4.6.4.3 Rest of Middle East and Africa Asthma Therapeutics Market by Route of administration
    10.5. SOUTH AND CENTRAL AMERICA
    10.5.1 South and Central America Asthma Therapeutics Market Overview
    10.5.2 South and Central America Asthma Therapeutics Market Forecasts and Analysis
    10.5.3 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Product Type
    10.5.4 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Drug Class
    10.5.5 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Route of administration
    10.5.6 South and Central America Asthma Therapeutics Market Forecasts and Analysis - By Countries
    10.5.6.1 Brazil Asthma Therapeutics Market
    10.5.6.1.1 Brazil Asthma Therapeutics Market by Product Type
    10.5.6.1.2 Brazil Asthma Therapeutics Market by Drug Class
    10.5.6.1.3 Brazil Asthma Therapeutics Market by Route of administration
    10.5.6.2 Argentina Asthma Therapeutics Market
    10.5.6.2.1 Argentina Asthma Therapeutics Market by Product Type
    10.5.6.2.2 Argentina Asthma Therapeutics Market by Drug Class
    10.5.6.2.3 Argentina Asthma Therapeutics Market by Route of administration
    10.5.6.3 Rest of South and Central America Asthma Therapeutics Market
    10.5.6.3.1 Rest of South and Central America Asthma Therapeutics Market by Product Type
    10.5.6.3.2 Rest of South and Central America Asthma Therapeutics Market by Drug Class
    10.5.6.3.3 Rest of South and Central America Asthma Therapeutics Market by Route of administration

    11. INDUSTRY LANDSCAPE
    11.1. MERGERS AND ACQUISITIONS
    11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
    11.3. NEW PRODUCT LAUNCHES
    11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

    12. ASTHMA THERAPEUTICS MARKET, KEY COMPANY PROFILES
    12.1. KONINKLIJKE PHILIPS N.V
    12.1.1. Key Facts
    12.1.2. Business Description
    12.1.3. Products and Services
    12.1.4. Financial Overview
    12.1.5. SWOT Analysis
    12.1.6. Key Developments
    12.2. ASTRAZENECA
    12.2.1. Key Facts
    12.2.2. Business Description
    12.2.3. Products and Services
    12.2.4. Financial Overview
    12.2.5. SWOT Analysis
    12.2.6. Key Developments
    12.3. GLAXOSMITHKLINE PLC.
    12.3.1. Key Facts
    12.3.2. Business Description
    12.3.3. Products and Services
    12.3.4. Financial Overview
    12.3.5. SWOT Analysis
    12.3.6. Key Developments
    12.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
    12.4.1. Key Facts
    12.4.2. Business Description
    12.4.3. Products and Services
    12.4.4. Financial Overview
    12.4.5. SWOT Analysis
    12.4.6. Key Developments
    12.5. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
    12.5.1. Key Facts
    12.5.2. Business Description
    12.5.3. Products and Services
    12.5.4. Financial Overview
    12.5.5. SWOT Analysis
    12.5.6. Key Developments
    12.6. SANOFI
    12.6.1. Key Facts
    12.6.2. Business Description
    12.6.3. Products and Services
    12.6.4. Financial Overview
    12.6.5. SWOT Analysis
    12.6.6. Key Developments
    12.7. CIPLA INC
    12.7.1. Key Facts
    12.7.2. Business Description
    12.7.3. Products and Services
    12.7.4. Financial Overview
    12.7.5. SWOT Analysis
    12.7.6. Key Developments
    12.8. INTAS PHARMACEUTICALS LTD
    12.8.1. Key Facts
    12.8.2. Business Description
    12.8.3. Products and Services
    12.8.4. Financial Overview
    12.8.5. SWOT Analysis
    12.8.6. Key Developments
    12.9. MERCK SHARP AND DOHME CORP
    12.9.1. Key Facts
    12.9.2. Business Description
    12.9.3. Products and Services
    12.9.4. Financial Overview
    12.9.5. SWOT Analysis
    12.9.6. Key Developments
    12.10. F. HOFFMANN-LA ROCHE LTD
    12.10.1. Key Facts
    12.10.2. Business Description
    12.10.3. Products and Services
    12.10.4. Financial Overview
    12.10.5. SWOT Analysis
    12.10.6. Key Developments

    13. APPENDIX
    13.1. ABOUT THE INSIGHT PARTNERS
    13.2. GLOSSARY OF TERMS
    The List of Companies

    - AstraZeneca
    - GlaxoSmithKline Plc.
    - Teva Pharmaceutical Industries Ltd.
    - Boehringer Ingelheim International GmbH
    - Sanofi
    - Cipla Inc
    - Intas Pharmaceuticals Ltd
    - Merck Sharp and Dohme Corp
    - F. Hoffmann-La Roche Ltd
    - Dr Reddy's Laboratories Ltd
    - Sunovion Pharmaceuticals, Inc
    - Abbott
    - Glenmark
    TIPRE00004065
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Pricing

    Free

    20%

    customization on Pre-Booking
    Request for Sample
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.